Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MANTIS trial of oral alendronate for avascular necrosis of the hip
2017-002798-21Phase 4Unknown
- Sponsor
- University of Oxford
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in osteonecrosis of the hip comparing Alendronate with Placebo (2 arms). Primary endpoint: Oxford Hip Score at 12 months. Status: unknown.
02
Drugs
alendronate
03
Conditions
osteonecrosis of the hip
Beyond the preview
Go deeper on 2017-002798-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002798-21.